Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Asia's shift towards more intensive farming is creating a platform for a wide-range of concerns for animal health.
US animal health firm ImmuCell has seen its sales dip by 26% in the second quarter of 2017.
Kindred Biosciences has said its pipeline of monoclonal antibodies (mAbs) are causing a stir among potential commercial collaborators.
Zoetis has launched the chewable version of its Clavamox antibiotic for dogs and cats in the US.
The US FDA hopes to use a biomass denominator as part of its quest for more accurate annual data concerning the level of antimicrobials sold or distributed for use in food-producing animals.
ECO Animal Health has added another authorization to its Aivlosin antibiotic portfolio, with Turkey the latest country to approve the product for use in commercial layers.
Merck Animal Health has gained US FDA approval for a respiratory and pain treatment for cattle.
US firms AntriaBio and ActiveSite Pharmaceuticals have signed a license and development agreement for oral plasma kallikrein inhibitors.
A new report from the European Food Safety Authority (EFSA), the European Medicines Agency and the European Centre for Disease Prevention and Control has drawn the link between antibiotic consumption and antibiotic resistance in both humans and animals, with more complete data compared to a similar report in 2015.
The European Medicines Agency (EMA) is taking a closer look at the use of aminoglycosides in animals to reduce the risk of antimicrobial resistance.
The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has approved Virbac Japan's EasOtic (hydrocortisone aceponate, miconazole nitrate, gentamicin sulphate) to treat infectious external otitis in dogs.
With the animal health sector currently experiencing a temporary lull in major M&A deals, the recent company rankings have remained fairly stable. However, to understand today's industry landscape, a history of consolidation has to be reviewed. Editor Joseph Harvey dug up Animal Pharm's time capsule to inspect over 25 years of comings and goings.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.